Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Stevens Negus

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Psychopharmacology|April 28, 2004
Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeysS Stevens Negus
The Journal of Pharmacology and Experimental Therapeutics|June 20, 2025
Determinants of drug effects in preclinical assays of pain-related behavioral depression: Considerations for analgesic drug developmentS Stevens Negus
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2015
Agonist Medications for the Treatment of Cocaine Use DisorderS Stevens Negus, Jack Henningfield
Experimental and Clinical Psychopharmacology|March 13, 2018
Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in ratsFarhana Sakloth, S Stevens Negus
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2007
Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeysNancy K Mello, S Stevens Negus
Psychopharmacology|March 26, 2003
Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeysS Stevens Negus, Nancy K Mello
Advances in Pharmacological Sciences|December 18, 2012
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-AdministrationMatthew L Banks, S Stevens Negus
Trends in Pharmacological Sciences|October 23, 2018
Abuse Potential of Biased Mu Opioid Receptor AgonistsS Stevens Negus, Kevin B Freeman
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
Monoamine transporter inhibitors and substrates as treatments for stimulant abuseLeonard L Howell, S Stevens Negus
Peptides|November 5, 2018
Determinants of opioid abuse potential: Insights using intracranial self-stimulationS Stevens Negus, Megan J Moerke
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Psychopharmacology|April 28, 2004
Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeysS Stevens Negus
The Journal of Pharmacology and Experimental Therapeutics|June 20, 2025
Determinants of drug effects in preclinical assays of pain-related behavioral depression: Considerations for analgesic drug developmentS Stevens Negus
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2015
Agonist Medications for the Treatment of Cocaine Use DisorderS Stevens Negus, Jack Henningfield
Experimental and Clinical Psychopharmacology|March 13, 2018
Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in ratsFarhana Sakloth, S Stevens Negus
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2007
Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeysNancy K Mello, S Stevens Negus
Psychopharmacology|March 26, 2003
Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeysS Stevens Negus, Nancy K Mello
Advances in Pharmacological Sciences|December 18, 2012
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-AdministrationMatthew L Banks, S Stevens Negus
Trends in Pharmacological Sciences|October 23, 2018
Abuse Potential of Biased Mu Opioid Receptor AgonistsS Stevens Negus, Kevin B Freeman
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
Monoamine transporter inhibitors and substrates as treatments for stimulant abuseLeonard L Howell, S Stevens Negus
Peptides|November 5, 2018
Determinants of opioid abuse potential: Insights using intracranial self-stimulationS Stevens Negus, Megan J Moerke
Pageof 20